{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T15:22:25Z","timestamp":1783351345812,"version":"3.54.6"},"reference-count":64,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,6,23]],"date-time":"2024-06-23T00:00:00Z","timestamp":1719100800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,6,23]],"date-time":"2024-06-23T00:00:00Z","timestamp":1719100800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82271094"],"award-info":[{"award-number":["82271094"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int Ophthalmol"],"DOI":"10.1007\/s10792-024-03192-9","type":"journal-article","created":{"date-parts":[[2024,6,23]],"date-time":"2024-06-23T01:01:11Z","timestamp":1719104471000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Update on lacrimal apparatus dysfunction associated with differentiated thyroid cancer after I-131 therapy"],"prefix":"10.1007","volume":"44","author":[{"given":"Chunlan","family":"Liang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Changlin","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5853-6268","authenticated-orcid":false,"given":"Lian","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5774-7602","authenticated-orcid":false,"given":"Jingxiang","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,6,23]]},"reference":[{"issue":"10","key":"3192_CR1","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.1089\/thy.2015.0116","volume":"25","author":"S Vaccarella","year":"2015","unstructured":"Vaccarella S, Dal Maso L, Laversanne M et al (2015) The impact of diagnostic changes on the rise in thyroid Cancer incidence: a Population-based study in selected high-resource countries. Thyroid 25(10):1127\u20131136. https:\/\/doi.org\/10.1089\/thy.2015.0116","journal-title":"Thyroid"},{"issue":"11","key":"3192_CR2","doi-asserted-by":"publisher","first-page":"2913","DOI":"10.1158\/0008-5472.Can-14-0155","volume":"74","author":"L Rahib","year":"2014","unstructured":"Rahib L, Smith BD, Aizenberg R et al (2014) Projecting cancer incidence and deaths to 2030: the unexpected burden of thyroid, liver, and pancreas cancers in the United States. Cancer Res 74(11):2913\u20132921. https:\/\/doi.org\/10.1158\/0008-5472.Can-14-0155","journal-title":"Cancer Res"},{"issue":"3","key":"3192_CR3","doi-asserted-by":"publisher","first-page":"257","DOI":"10.4274\/jcrpe.galenos.2023.2023-1-16","volume":"15","author":"C Chiapponi","year":"2023","unstructured":"Chiapponi C, Hartmann MJM, Decarolis B et al (2023) Differentiated thyroid cancer in adolescents: single center experience and considerations for surgical management and radioiodine treatment. J Clin Res Pediatr Endocrinol 15(3):257\u2013263. https:\/\/doi.org\/10.4274\/jcrpe.galenos.2023.2023-1-16","journal-title":"J Clin Res Pediatr Endocrinol"},{"issue":"4","key":"3192_CR4","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1530\/eje.1.02257","volume":"155","author":"G Riesco-Eizaguirre","year":"2006","unstructured":"Riesco-Eizaguirre G, Santisteban P (2006) A perspective view of sodium iodide symporter research and its clinical implications. Eur J Endocrinol 155(4):495\u2013512. https:\/\/doi.org\/10.1530\/eje.1.02257","journal-title":"Eur J Endocrinol"},{"issue":"12","key":"3192_CR5","doi-asserted-by":"publisher","first-page":"1164","DOI":"10.3969\/j.ssn.1674-0904.2021.12.013","volume":"34","author":"Guidelines Working Committee of Chinese Society of Clinical Oncology","year":"2021","unstructured":"Guidelines Working Committee of Chinese Society of Clinical Oncology (2021) Guidelines of Chinese society of clinical 0ncology (CSCO) dilerentiated thyroid Cancer. Cancer Control Treat. 34(12):1164\u20131201. https:\/\/doi.org\/10.3969\/j.ssn.1674-0904.2021.12.013","journal-title":"Cancer Control Treat."},{"key":"3192_CR6","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24108678","author":"W Nurhidayah","year":"2023","unstructured":"Nurhidayah W, Widyasari EM, Daruwati I et al (2023) Radiosynthesis, stability, lipophilicity, and cellular uptake evaluations of [(131)I]Iodine-\u03b1-Mangostin for breast cancer diagnosis and therapy. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms24108678","journal-title":"Int J Mol Sci"},{"key":"3192_CR7","doi-asserted-by":"publisher","unstructured":"Glazer DI, Brown RK, Wong KK et al (2013) SPECT\/CT evaluation of unusual physiologic radioiodine biodistributions: pearls and pitfalls in image interpretation. Radiograph Rev Publ Radiol Soc North Am Inc 33(2):397\u2013418. https:\/\/doi.org\/10.1148\/rg.332125051","DOI":"10.1148\/rg.332125051"},{"issue":"10","key":"3192_CR8","doi-asserted-by":"publisher","first-page":"T167","DOI":"10.1530\/erc-21-0035","volume":"28","author":"SM Jhiang","year":"2021","unstructured":"Jhiang SM, Sipos JA (2021) Na+\/I- symporter expression, function, and regulation in non-thyroidal tissues and impact on thyroid cancer therapy. Endocrine-related Cancer 28(10):T167-t177. https:\/\/doi.org\/10.1530\/erc-21-0035","journal-title":"Endocrine-related Cancer"},{"issue":"11","key":"3192_CR9","doi-asserted-by":"publisher","first-page":"4178","DOI":"10.1210\/jcem.84.11.6117","volume":"84","author":"C Spitzweg","year":"1999","unstructured":"Spitzweg C, Joba W, Schriever K et al (1999) Analysis of human sodium iodide symporter immunoreactivity in human exocrine glands. J Clin Endocrinol Metab 84(11):4178\u20134184. https:\/\/doi.org\/10.1210\/jcem.84.11.6117","journal-title":"J Clin Endocrinol Metab"},{"issue":"8","key":"3192_CR10","doi-asserted-by":"publisher","first-page":"808","DOI":"10.1097\/mnm.0000000000000132","volume":"35","author":"A Fard-Esfahani","year":"2014","unstructured":"Fard-Esfahani A, Emami-Ardekani A, Fallahi B et al (2014) Adverse effects of radioactive iodine-131 treatment for differentiated thyroid carcinoma. Nucl Med Commun 35(8):808\u2013817. https:\/\/doi.org\/10.1097\/mnm.0000000000000132","journal-title":"Nucl Med Commun"},{"issue":"10","key":"3192_CR11","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1016\/j.ctrv.2015.09.001","volume":"41","author":"SC Clement","year":"2015","unstructured":"Clement SC, Peeters RP, Ronckers CM et al (2015) Intermediate and long-term adverse effects of radioiodine therapy for differentiated thyroid carcinoma\u2013a systematic review. Cancer Treat Rev 41(10):925\u2013934. https:\/\/doi.org\/10.1016\/j.ctrv.2015.09.001","journal-title":"Cancer Treat Rev"},{"key":"3192_CR12","doi-asserted-by":"publisher","unstructured":"Zettinig G, Hanselmayer G, Fueger BJ et al (2002)long-term impairment of the lacrimal glands after radioiodine therapy: a cross-sectional study. Eur J Nucl Med Mol Imaging 29 (11): 1428\u20131432. https:\/\/doi.org\/10.1007\/s00259-002-0969-0","DOI":"10.1007\/s00259-002-0969-0"},{"key":"3192_CR13","unstructured":"Solans R, Bosch JA, Galofr\u00e9 P et Al(2001)salivary and lacrimal gland dysfunction (sicca syndrome) after radioiodine therapy. J Nucl Med 42 (5): 738\u2013743. https:\/\/pubmed.ncbi.nlm.nih.gov\/11337569\/"},{"issue":"12","key":"3192_CR14","doi-asserted-by":"publisher","first-page":"2381","DOI":"10.1002\/hed.24895","volume":"39","author":"FL da Fonseca","year":"2017","unstructured":"da Fonseca FL, Yamanaka PK, Mazoti L et al (2017) Correlation among ocular surface disease, xerostomia, and nasal symptoms in patients with differentiated thyroid carcinoma subjected to radioiodine therapy: a prospective comparative study. Head Neck 39(12):2381\u20132396. https:\/\/doi.org\/10.1002\/hed.24895","journal-title":"Head Neck"},{"issue":"2","key":"3192_CR15","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1590\/s0004-27492012000200005","volume":"75","author":"FL Fonseca","year":"2012","unstructured":"Fonseca FL, Lunardelli P, Matayoshi S (2012) Lacrimal drainage system obstruction associated to radioactive iodine therapy for thyroid carcinoma. Arq Bras Oftalmol 75(2):97\u2013100. https:\/\/doi.org\/10.1590\/s0004-27492012000200005","journal-title":"Arq Bras Oftalmol"},{"issue":"2","key":"3192_CR16","doi-asserted-by":"publisher","first-page":"87","DOI":"10.3121\/cmr.2007.763","volume":"5","author":"SA Doi","year":"2007","unstructured":"Doi SA, Woodhouse NJ, Thalib L et al (2007) Ablation of the thyroid remnant and I-131 dose in differentiated thyroid cancer: a meta-analysis revisited. Clin Med Res 5(2):87\u201390. https:\/\/doi.org\/10.3121\/cmr.2007.763","journal-title":"Clin Med Res"},{"issue":"9","key":"3192_CR17","doi-asserted-by":"publisher","first-page":"3385","DOI":"10.1007\/s10792-023-02746-7","volume":"43","author":"VD Yartsev","year":"2023","unstructured":"Yartsev VD, Atkova EL, Ekaterinchev MA (2023) Topographic and anatomical features of the nasolacrimal duct obstruction due to radioiodine treatment. Int Ophthalmol 43(9):3385\u20133390. https:\/\/doi.org\/10.1007\/s10792-023-02746-7","journal-title":"Int Ophthalmol"},{"issue":"5","key":"3192_CR18","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1097\/01.iop.0000179369.75569.a8","volume":"21","author":"KE Morgenstern","year":"2005","unstructured":"Morgenstern KE, Vadysirisack DD, Zhang Z et al (2005) Expression of sodium iodide symporter in the lacrimal drainage system: implication for the mechanism underlying nasolacrimal duct obstruction in I(131)-treated patients. Ophthalmic Plast Reconstr Surg 21(5):337\u2013344. https:\/\/doi.org\/10.1097\/01.iop.0000179369.75569.a8","journal-title":"Ophthalmic Plast Reconstr Surg"},{"key":"3192_CR19","doi-asserted-by":"publisher","first-page":"2479","DOI":"10.2147\/opth.S71708","volume":"8","author":"KH Al-Qahtani","year":"2014","unstructured":"Al-Qahtani KH, Al Asiri M, Tunio MA et al (2014) Nasolacrimal duct obstruction following radioactive iodine 131 therapy in differentiated thyroid cancers: review of 19 cases. Clin Ophthalmol 8:2479\u20132484. https:\/\/doi.org\/10.2147\/opth.S71708","journal-title":"Clin Ophthalmol"},{"key":"3192_CR20","doi-asserted-by":"publisher","DOI":"10.1177\/01455613231170088","author":"N Li","year":"2023","unstructured":"Li N, Zhang W (2023) Clinical characteristics of nasolacrimal duct obstruction after iodine therapy in differentiated thyroid cancer patients. Ear Nose Throat J. https:\/\/doi.org\/10.1177\/01455613231170088","journal-title":"Ear Nose Throat J"},{"issue":"9","key":"3192_CR21","doi-asserted-by":"publisher","first-page":"1320","DOI":"10.1080\/02713683.2021.1878229","volume":"46","author":"VD Yartsev","year":"2021","unstructured":"Yartsev VD, Solodkiy VA, Fomin DK et al (2021) Clinical and demographic characteristics of tearing in patients after Radioiodine ablation for differentiated thyroid Cancer. Curr Eye Res 46(9):1320\u20131324. https:\/\/doi.org\/10.1080\/02713683.2021.1878229","journal-title":"Curr Eye Res"},{"issue":"12","key":"3192_CR22","doi-asserted-by":"publisher","first-page":"1210","DOI":"10.1016\/j.eprac.2022.08.006","volume":"28","author":"IT Lee","year":"2022","unstructured":"Lee IT, Chen W, Chen Q et al (2022) Factors associated with radioactive Iodine therapy-acquired nasolacrimal duct obstruction. Endocr Pract 28(12):1210\u20131215. https:\/\/doi.org\/10.1016\/j.eprac.2022.08.006","journal-title":"Endocr Pract"},{"issue":"5","key":"3192_CR23","doi-asserted-by":"publisher","first-page":"1828","DOI":"10.4103\/ijo.Ijo_2780_22","volume":"71","author":"VD Yartsev","year":"2023","unstructured":"Yartsev VD, Sheremeta MS, Trukhin AA et al (2023) Dependence of radioactive iodine-131 capture by the lacrimal ducts on the tear production level. Indian J Ophthalmol 71(5):1828\u20131832. https:\/\/doi.org\/10.4103\/ijo.Ijo_2780_22","journal-title":"Indian J Ophthalmol"},{"issue":"9","key":"3192_CR24","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1097\/RLU.0b013e318124fdb6","volume":"32","author":"A Fard-Esfahani","year":"2007","unstructured":"Fard-Esfahani A, Mirshekarpour H, Fallahi B et al (2007) The effect of high-dose radioiodine treatment on lacrimal gland function in patients with differentiated thyroid carcinoma. Clin Nucl Med 32(9):696\u2013699. https:\/\/doi.org\/10.1097\/RLU.0b013e318124fdb6","journal-title":"Clin Nucl Med"},{"key":"3192_CR25","doi-asserted-by":"publisher","first-page":"101193","DOI":"10.1016\/j.preteyeres.2023.101193","volume":"96","author":"MJ Ali","year":"2023","unstructured":"Ali MJ (2023) Etiopathogenesis of primary acquired nasolacrimal duct obstruction (PANDO). Prog Retin Eye Res 96:101193. https:\/\/doi.org\/10.1016\/j.preteyeres.2023.101193","journal-title":"Prog Retin Eye Res"},{"issue":"1","key":"3192_CR26","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1080\/15569527.2018.1498507","volume":"38","author":"U Eksioglu","year":"2019","unstructured":"Eksioglu U, Atilgan HI, Yakin M et al (2019) Antioxidant effects of vitamin D on lacrimal glands against high dose radioiodine-associated damage in an animal model. Cutan Ocul Toxicol 38(1):18\u201324. https:\/\/doi.org\/10.1080\/15569527.2018.1498507","journal-title":"Cutan Ocul Toxicol"},{"issue":"3","key":"3192_CR27","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1080\/02713683.2020.1803920","volume":"46","author":"G Koca","year":"2021","unstructured":"Koca G, Singar E, Akbulut A et al (2021) The effect of resveratrol on radioiodine therapy-associated lacrimal gland damage. Curr Eye Res 46(3):398\u2013407. https:\/\/doi.org\/10.1080\/02713683.2020.1803920","journal-title":"Curr Eye Res"},{"issue":"3","key":"3192_CR28","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1097\/iop.0000000000001521","volume":"36","author":"AA Fedorov","year":"2020","unstructured":"Fedorov AA, Atkova EL, Yartsev VD (2020) Secondary acquired nasolacrimal duct obstruction as a specific complication of treatment with radioactive Iodine (Morphological Study). Ophthalmic Plast Reconstr Surg 36(3):250\u2013253. https:\/\/doi.org\/10.1097\/iop.0000000000001521","journal-title":"Ophthalmic Plast Reconstr Surg"},{"key":"3192_CR29","doi-asserted-by":"publisher","unstructured":"Usmani S, Jain A, Al-Riyami K et al (2023) Accumulation of 131 Iodine in the nasolacrimal sac\/duct after radioiodine therapy for papillary thyroid cancer. J Pak Med Assoc 73(3): 713\u2013714. https:\/\/doi.org\/10.47391\/jpma.23-22","DOI":"10.47391\/jpma.23-22"},{"issue":"1","key":"3192_CR30","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1089\/thy.2023.0338","volume":"34","author":"IT Lee","year":"2024","unstructured":"Lee IT, Grice JV, Ji X et al (2024) A pilot nonrandomized controlled trial examining the use of artificial tears on the radioactivity of tears after radioactive Iodine treatment for thyroid cancer. Thyroid 34(1):82\u201387. https:\/\/doi.org\/10.1089\/thy.2023.0338","journal-title":"Thyroid"},{"issue":"8","key":"3192_CR31","first-page":"1452","volume":"39","author":"SM Bakheet","year":"1998","unstructured":"Bakheet SM, Hammami MM, Hemidan A et al (1998) Radioiodine secretion in tears. J Nucl Med 39(8):1452\u20131454","journal-title":"J Nucl Med"},{"issue":"10","key":"3192_CR32","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1097\/00006231-200010000-00010","volume":"21","author":"G Zettinig","year":"2000","unstructured":"Zettinig G, Karanikas G, Hanselmayer G et al (2000) Radioactive contamination of contact lenses during radioiodine therapy. Nucl Med Commun 21(10):955\u2013957. https:\/\/doi.org\/10.1097\/00006231-200010000-00010","journal-title":"Nucl Med Commun"},{"issue":"4","key":"3192_CR33","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1021\/bi035382a","volume":"43","author":"CJ Ketchum","year":"2004","unstructured":"Ketchum CJ, Rajendrakumar GV, Maloney PC (2004) Characterization of the adenosinetriphosphatase and transport activities of purified cystic fibrosis transmembrane conductance regulator. Biochemistry 43(4):1045\u20131053. https:\/\/doi.org\/10.1021\/bi035382a","journal-title":"Biochemistry"},{"issue":"1","key":"3192_CR34","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1210\/jcem-28-1-1","volume":"28","author":"M Berman","year":"1968","unstructured":"Berman M, Hoff E, Barandes M et al (1968) Iodine kinetics in man\u2013a model. J Clin Endocrinol Metab 28(1):1\u201314. https:\/\/doi.org\/10.1210\/jcem-28-1-1","journal-title":"J Clin Endocrinol Metab"},{"key":"3192_CR35","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.jtos.2022.11.003","volume":"27","author":"S Singh","year":"2023","unstructured":"Singh S, Hammer CM, Paulsen F (2023) Urea and ocular surface: synthesis, secretion and its role in tear film homeostasis. Ocul Surf 27:41\u201347. https:\/\/doi.org\/10.1016\/j.jtos.2022.11.003","journal-title":"Ocul Surf"},{"issue":"4","key":"3192_CR36","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1007\/s13167-021-00265-y","volume":"12","author":"X Zhan","year":"2021","unstructured":"Zhan X, Li J, Guo Y et al (2021) Mass spectrometry analysis of human tear fluid biomarkers specific for ocular and systemic diseases in the context of 3P medicine. EPMA J 12(4):449\u2013475. https:\/\/doi.org\/10.1007\/s13167-021-00265-y","journal-title":"EPMA J"},{"key":"3192_CR37","doi-asserted-by":"publisher","unstructured":"Chudgar AV, Shah JC (2017) Pictorial Review of False-Positive Results on Radioiodine scintigrams of patients with differentiated thyroid Cancer. Radiogr Rev Publ Radiol Soc North Am Inc 37(1): 298\u2013315. https:\/\/doi.org\/10.1148\/rg.2017160074","DOI":"10.1148\/rg.2017160074"},{"issue":"5","key":"3192_CR38","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1007\/bf02984488","volume":"18","author":"PO Kiratli","year":"2004","unstructured":"Kiratli PO, Kara PP, Erg\u00fcn EL et al (2004) Metastatic insular thyroid carcinoma: visualized on Tc-99m pertechnetate, Tc-99m MDP and iodine-131 scintigraphy; a review of the literature for other radionuclide agents. Ann Nucl Med 18(5):443\u2013446. https:\/\/doi.org\/10.1007\/bf02984488","journal-title":"Ann Nucl Med"},{"issue":"1","key":"3192_CR39","doi-asserted-by":"publisher","first-page":"e9329","DOI":"10.5812\/ijem.9329","volume":"12","author":"P Ozcan Kara","year":"2014","unstructured":"Ozcan Kara P, Gunay EC, Erdogan A (2014) Radioiodine Contamination artifacts and unusual patterns of Accumulation in whole-body I-131 imaging: a Case Series. Int J Endocrinol Metabolism 12(1):e9329. https:\/\/doi.org\/10.5812\/ijem.9329","journal-title":"Int J Endocrinol Metabolism"},{"key":"3192_CR40","doi-asserted-by":"publisher","unstructured":"Levy O, De la Vieja A, Ginter CS et al (1998) N-linked glycosylation of the thyroid Na+\/I- symporter (NIS). Implications for its secondary structure model. J Biol Chem 273(35): 22657\u201322663. https:\/\/doi.org\/10.1074\/jbc.273.35.22657","DOI":"10.1074\/jbc.273.35.22657"},{"issue":"1","key":"3192_CR41","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1097\/iop.0000000000000603","volume":"33","author":"MJ Ali","year":"2017","unstructured":"Ali MJ, Vyakaranam AR, Rao JE et al (2017) Iodine-131 therapy and lacrimal drainage system toxicity: nasal localization studies using whole body nuclear scintigraphy and SPECT-CT. Ophthalmic Plast Reconstr Surg 33(1):13\u201316. https:\/\/doi.org\/10.1097\/iop.0000000000000603","journal-title":"Ophthalmic Plast Reconstr Surg"},{"issue":"9","key":"3192_CR42","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1007\/s12149-007-0056-5","volume":"21","author":"H Sakahara","year":"2007","unstructured":"Sakahara H, Yamashita S, Suzuki K et al (2007) Visualization of nasolacrimal drainage system after radioiodine therapy in patients with thyroid cancer. Ann Nucl Med 21(9):525\u2013527. https:\/\/doi.org\/10.1007\/s12149-007-0056-5","journal-title":"Ann Nucl Med"},{"issue":"12","key":"3192_CR43","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.1097\/RLU.0b013e3182336016","volume":"36","author":"S Yuoness","year":"2011","unstructured":"Yuoness S, Rachinsky I, Driedger AA et al (2011) Differentiated thyroid cancer with epiphora: detection of nasolacrimal duct obstruction on I-131 SPECT\/CT. Clin Nuclear Med 36(12):1149\u20131152. https:\/\/doi.org\/10.1097\/RLU.0b013e3182336016","journal-title":"Clin Nuclear Med"},{"issue":"3","key":"3192_CR44","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1016\/0030-4220(93)90144-s","volume":"75","author":"A Markitziu","year":"1993","unstructured":"Markitziu A, Lustmann J, Uzieli B et al (1993) Salivary and lacrimal gland involvement in a patient who had undergone a thyroidectomy and was treated with radioiodine for thyroid cancer. Oral Surg Oral Med Oral Pathol 75(3):318\u2013322. https:\/\/doi.org\/10.1016\/0030-4220(93)90144-s","journal-title":"Oral Surg Oral Med Oral Pathol"},{"issue":"5","key":"3192_CR45","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1016\/j.remn.2013.01.006","volume":"32","author":"G Koca","year":"2013","unstructured":"Koca G, Yalniz-Akkaya Z, G\u00fcltekin SS et al (2013) Radioprotective effect of montelukast sodium in rat lacrimal glands after radioiodine treatment. Rev Esp Med Nucl Imagen Mol 32(5):294\u2013300. https:\/\/doi.org\/10.1016\/j.remn.2013.01.006","journal-title":"Rev Esp Med Nucl Imagen Mol"},{"issue":"7","key":"3192_CR46","doi-asserted-by":"publisher","first-page":"659","DOI":"10.3109\/02713683.2013.867354","volume":"39","author":"DE Acar","year":"2014","unstructured":"Acar DE, Acar U, Yumusak N et al (2014) Reducing the histopathological changes of radioiodine to the lacrimal glands by a popular anti-oxidant: lycopene. Curr Eye Res 39(7):659\u2013665. https:\/\/doi.org\/10.3109\/02713683.2013.867354","journal-title":"Curr Eye Res"},{"issue":"10","key":"3192_CR47","doi-asserted-by":"publisher","first-page":"886","DOI":"10.1007\/s12149-013-0763-z","volume":"27","author":"U Acar","year":"2013","unstructured":"Acar U, Atilgan HI, Acar DE et al (2013) The effect of short-term vitamin E against radioiodine-induced early lacrimal gland damage. Ann Nucl Med 27(10):886\u2013891. https:\/\/doi.org\/10.1007\/s12149-013-0763-z","journal-title":"Ann Nucl Med"},{"issue":"1","key":"3192_CR48","doi-asserted-by":"publisher","first-page":"35","DOI":"10.5935\/0004-2749.20170010","volume":"80","author":"F Ornek","year":"2017","unstructured":"Ornek F, Acar DE, Acar U et al (2017) Short- and long-term effects of zinc treatment on lacrimal gland histopathology and tear functions tests in radioiodine-administered rats. Arq Bras Oftalmol 80(1):35\u201340. https:\/\/doi.org\/10.5935\/0004-2749.20170010","journal-title":"Arq Bras Oftalmol"},{"issue":"12","key":"3192_CR49","doi-asserted-by":"publisher","first-page":"1590","DOI":"10.1080\/02713683.2017.1362006","volume":"42","author":"M Yakin","year":"2017","unstructured":"Yakin M, Eksioglu U, Sadic M et al (2017) Coenzyme Q10 for the protection of lacrimal gland against high-dose radioiodine therapy-associated oxidative damage: histopathologic and tissue cytokine level assessments in an animal model. Curr Eye Res 42(12):1590\u20131596. https:\/\/doi.org\/10.1080\/02713683.2017.1362006","journal-title":"Curr Eye Res"},{"issue":"2","key":"3192_CR50","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1080\/09273948.2022.2026409","volume":"31","author":"HI Atilgan","year":"2023","unstructured":"Atilgan HI, Akbulut A, Yazihan N et al (2023) The cytokines-Directed roles of spirulina for radioprotection of lacrimal gland. Ocular Immunol Inflamm 31(2):271\u2013276. https:\/\/doi.org\/10.1080\/09273948.2022.2026409","journal-title":"Ocular Immunol Inflamm"},{"key":"3192_CR51","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1146\/annurev-physiol-022516-034125","volume":"79","author":"S Ravera","year":"2017","unstructured":"Ravera S, Reyna-Neyra A, Ferrandino G et al (2017) The Sodium\/Iodide Symporter (NIS): molecular physiology and preclinical and clinical applications. Annu Rev Physiol 79:261\u2013289. https:\/\/doi.org\/10.1146\/annurev-physiol-022516-034125","journal-title":"Annu Rev Physiol"},{"issue":"2","key":"3192_CR52","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1097\/01.iop.0000117340.41849.81","volume":"20","author":"JA Burns","year":"2004","unstructured":"Burns JA, Morgenstern KE, Cahill KV et al (2004) Nasolacrimal obstruction secondary to I(131) therapy. Ophthalmic Plast Reconstr Surg 20(2):126\u2013129. https:\/\/doi.org\/10.1097\/01.iop.0000117340.41849.81","journal-title":"Ophthalmic Plast Reconstr Surg"},{"issue":"1","key":"3192_CR53","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1089\/thy.2023.0338","volume":"34","author":"IT Lee","year":"2023","unstructured":"Lee IT, Grice JV, Ji X et al (2023) A pilot nonrandomized controlled trial examining the use of artificial tears on the radioactivity of tears after radioactive Iodine treatment for thyroid cancer. Thyroid 34(1):82\u201387. https:\/\/doi.org\/10.1089\/thy.2023.0338","journal-title":"Thyroid"},{"key":"3192_CR54","doi-asserted-by":"publisher","unstructured":"Jung SK, Kim YC, Cho WK et al (2015) Surgical outcomes of endoscopic dacryocystorhinostomy: analysis of 1083 consecutive cases. Canadian journal of ophthalmology. J Canadien d\u2019ophtalmologie 50(6): 466\u2013470. https:\/\/doi.org\/10.1016\/j.jcjo.2015.08.007","DOI":"10.1016\/j.jcjo.2015.08.007"},{"issue":"1","key":"3192_CR55","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1097\/iop.0000000000000841","volume":"34","author":"AR Sweeney","year":"2018","unstructured":"Sweeney AR, Davis GE, Chang SH et al (2018) Outcomes of endoscopic dacryocystorhinostomy in secondary acquired nasolacrimal duct obstruction: a case-control study. Ophthalmic Plast Reconstr Surg 34(1):20\u201325. https:\/\/doi.org\/10.1097\/iop.0000000000000841","journal-title":"Ophthalmic Plast Reconstr Surg"},{"issue":"10","key":"3192_CR56","doi-asserted-by":"publisher","first-page":"3290","DOI":"10.4103\/ijo.Ijo_3334_22","volume":"71","author":"BB Panda","year":"2023","unstructured":"Panda BB, Nayak B, Mohapatra S et al (2023) Success and complications of endoscopic laser dacryocystorhinostomy vs. external dacryocystorhinostomy: a systematic review and meta-analysis. Indian J Ophthalmol 71(10):3290\u20133298. https:\/\/doi.org\/10.4103\/ijo.Ijo_3334_22","journal-title":"Indian J Ophthalmol"},{"issue":"1","key":"3192_CR57","doi-asserted-by":"publisher","first-page":"1","DOI":"10.4103\/meajo.meajo_238_21","volume":"29","author":"MT Rajabi","year":"2022","unstructured":"Rajabi MT, Shahraki K, Nozare A et al (2022) External versus endoscopic dacryocystorhinostomy for primary acquired nasolacrimal duct obstruction. Middle East Afr J Ophthalmol 29(1):1\u20136. https:\/\/doi.org\/10.4103\/meajo.meajo_238_21","journal-title":"Middle East Afr J Ophthalmol"},{"issue":"2","key":"3192_CR58","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1001\/archotol.129.2.233","volume":"129","author":"K Bakri","year":"2003","unstructured":"Bakri K, Jones NS, Downes R et al (2003) Intraoperative fluorouracil in endonasal laser dacryocystorhinostomy. Arch Otolaryngol Head Neck Surg 129(2):233\u2013235. https:\/\/doi.org\/10.1001\/archotol.129.2.233","journal-title":"Arch Otolaryngol Head Neck Surg"},{"issue":"6","key":"3192_CR59","doi-asserted-by":"publisher","first-page":"704","DOI":"10.3980\/j.issn.2222-3959.2012.06.10","volume":"5","author":"QS Ji","year":"2012","unstructured":"Ji QS, Zhong JX, Tu YH et al (2012) New mucosal flap modification for endonasal endoscopic dacryocystorhinostomy in asians. Int J Ophthalmol 5(6):704\u2013707. https:\/\/doi.org\/10.3980\/j.issn.2222-3959.2012.06.10","journal-title":"Int J Ophthalmol"},{"issue":"5","key":"3192_CR60","doi-asserted-by":"publisher","first-page":"e62737","DOI":"10.1371\/journal.pone.0062737","volume":"8","author":"SM Cheng","year":"2013","unstructured":"Cheng SM, Feng YF, Xu L et al (2013) Efficacy of mitomycin C in endoscopic dacryocystorhinostomy: a systematic review and meta-analysis. PLoS ONE 8(5):e62737. https:\/\/doi.org\/10.1371\/journal.pone.0062737","journal-title":"PLoS ONE"},{"issue":"3","key":"3192_CR61","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/j.amjoto.2014.02.006","volume":"35","author":"DM Chan","year":"2014","unstructured":"Chan DM, Golubev I, Shipchandler TZ et al (2014) Improving outcomes by combining septoplasty with primary external dacryocystorhinostomy. Am J Otolaryngol 35(3):309\u2013312. https:\/\/doi.org\/10.1016\/j.amjoto.2014.02.006","journal-title":"Am J Otolaryngol"},{"issue":"1","key":"3192_CR62","doi-asserted-by":"publisher","first-page":"63","DOI":"10.2500\/ajra.2015.29.4119","volume":"29","author":"S Okuyucu","year":"2015","unstructured":"Okuyucu S, Gorur H, Oksuz H et al (2015) Endoscopic dacryocystorhinostomy with silicone, polypropylene, and T-tube stents; randomized controlled trial of efficacy and safety. Am J Rhinol Allergy 29(1):63\u201368. https:\/\/doi.org\/10.2500\/ajra.2015.29.4119","journal-title":"Am J Rhinol Allergy"},{"issue":"12","key":"3192_CR63","doi-asserted-by":"publisher","first-page":"1361","DOI":"10.1001\/jamaophthalmol.2017.4798","volume":"135","author":"EY Li","year":"2017","unstructured":"Li EY, Wong ES, Wong AC et al (2017) Primary vs secondary endoscopic dacryocystorhinostomy for Acute Dacryocystitis with lacrimal sac abscess formation: a randomized clinical trial. JAMA Ophthalmol 135(12):1361\u20131366. https:\/\/doi.org\/10.1001\/jamaophthalmol.2017.4798","journal-title":"JAMA Ophthalmol"},{"issue":"1","key":"3192_CR64","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1177\/19458924221126356","volume":"37","author":"J Li","year":"2023","unstructured":"Li J, Wang J, Sun C (2023) Efficacy of hyaluronic acid in endoscopic dacryocystorhinostomy: a systematic review and Meta-analysis. Am J Rhinol Allergy 37(1):102\u2013109. https:\/\/doi.org\/10.1177\/19458924221126356","journal-title":"Am J Rhinol Allergy"}],"container-title":["International Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10792-024-03192-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10792-024-03192-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10792-024-03192-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,13]],"date-time":"2025-03-13T15:35:08Z","timestamp":1741880108000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10792-024-03192-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,23]]},"references-count":64,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["3192"],"URL":"https:\/\/doi.org\/10.1007\/s10792-024-03192-9","relation":{},"ISSN":["1573-2630"],"issn-type":[{"value":"1573-2630","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,6,23]]},"assertion":[{"value":"27 February 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 June 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 June 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"257"}}